Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
Clinical trial NCT07303777 · RECRUITING
Trial details
- NCT number
- NCT07303777
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2028-01-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.